Learn / CTMX
NASDAQ: CTMX
CytomX Therapeutics (CTMX) stock, explained like you're 5
CytomX Therapeutics trades on the Nasdaq under the ticker CTMX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 560 million dollars.
- Ticker
- CTMX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 560 million dollars
Is CytomX Therapeutics a small, medium or large cap company?
No. CytomX Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 560 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How CytomX Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CTMX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- CytomX Therapeutics (NasdaqGS:CTMX) Stock Forecast & Analyst Predictions (Simply Wall Street)
- CEO exercised options and sold 101,793 CytomX Therapeutics (CTMX) shares under a trading plan. (Stock Titan)
- Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now? (Yahoo Finance)
- Form 4 CytomX Therapeutics Inc: Sean A. McCarthy (Director, CEO) For: 6 November By Investing.com (Investing.com South Africa)
- CytomX Therapeutics stock closed at USD 2.28, down 5.39 percent on October 16 (ad-hoc-news.de)
Follow CTMX in your daily brief
Each trading day at 5 PM ET we post what happened to CytomX Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CTMX
Questions about CytomX Therapeutics stock
What does CytomX Therapeutics do?
CytomX Therapeutics trades on the Nasdaq under the ticker CTMX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 560 million dollars.
What is the ticker symbol for CytomX Therapeutics?
CytomX Therapeutics trades under the ticker CTMX on the Nasdaq.
What is CytomX Therapeutics's market cap?
CytomX Therapeutics is a small cap stock with a market cap of about 560 million dollars.
How does CytomX Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CTMX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CTMX stock every day?
Add CTMX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.